Mark Lowenberg - Department of Gastroenterology and Hepatology, University of Amsterdam

基本信息

浏览量：147

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 271 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Higher Vedolizumab Clearance Associates with Poor Therapeutic Outcomes During Maintenance Therapy of Vedolizumab in Crohn's Disease

S. Anjie,G. R. A. M. D'Haens,F. Baert,P. Bossuyt,F. Hoentjen,E. Clasquin,T. Molnar,M. Lowenberg,S. Vermeire, J. C. Panetta,T. Dervieux

JOURNAL OF CROHNS & COLITIS (2025): i1807-i1807

引用0浏览0引用

Histone Serotonylation (h3q5ser): A Novel Epigenetic Signature in Crohn's Disease Pathogenesis

J. Li, K. Overberg, P. Metselaar,A. te Velde,M. Lowenberg,G. D'Haens, J. Derikx,W. de Jonge,M. Ghiboub

JOURNAL OF CROHNS & COLITIS (2025): i639-i639

引用0浏览0引用

Obesity is Associated with Inferior Treatment Outcomes in Inflammatory Bowel Disease: a Nationwide Dutch Registry Study

D. Oomkens,Z. Mujagic,A. de Vries,A. van der Meulen-de Jong,T. Straatmijer,M. Lowenberg,S. van der Marel,R. West,A. Bodelier,F. van Schaik,M. Visschedijk,M. Duijvestein

JOURNAL OF CROHNS & COLITIS (2025): i1213-i1213

引用0浏览0引用

FAPi PET/CT Imaging to Identify Fibrosis in Immune-Mediated Inflammatory Diseases

Dalia A Lartey, Lynn A Schilder, Gerben J C Zwezerijnen, Geert R A M D'Haens,Joep Grootjans,Mark Löwenberg

Biomedicinesno. 4 (2025)

引用0浏览0WOS引用

Immunogenicity and Efficacy of Subcutaneous Infliximab Monotherapy Vs Combination Therapy in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis

Suzanne I Anjie, Krisztina B Gecse, Chiara M Meloni, Andrés Vidal-Itriago,Mark Löwenberg, Geert R D'Haens

Clinical gastroenterology and hepatology the official clinical practice journal of the American Gastroenterological Association (2025)

引用0浏览0WOS引用

Mucosal Healing with Vedolizumab in Patients with Chronic Controlled Trial

Vipul Jairath,Brian G. Feagan,Mark S. Silverberg,Silvio Danese,Paolo Gionchetti,Mark Lowenberg,Brian Bressler,Marc Ferrante,Ailsa Hart,Dirk Lindner,Armella Escher,Stephen Jones,Bo Shen,Simon Travis

CLINICAL GASTROENTEROLOGY AND HEPATOLOGYno. 2 (2025)

引用0浏览0引用

Real-world Effectiveness and Safety of Filgotinib with and Without Concomitant Therapies in Patients with Ulcerative Colitis: an Interim Analysis of the Prospective, Observational GALOCEAN Study

M. Hoivik,S. Vermeire,W. Reinisch,J. P. Seenan,M. Lowenberg,S. Schreiber,A. Armuzzi, E. Ricart,G. Doherty, R. Saldana, W. Sawyer,C. Rudolph, A. Jus, C. Gilletta de Saint Joseph

JOURNAL OF CROHNS & COLITIS (2025): i1884-i1885

引用0浏览0引用

In Silico Drug Repurposing Approach for the Discovery of Therapeutics for Intestinal Fibrosis in Crohn's Disease

D. Nikolakis, A. Y. F. Li Yim, D. Lartey, F. Rieder,G. R. D'Haens,M. G. H. van de Sande,M. Lowenberg

JOURNAL OF CROHNS & COLITIS（2025）

引用0浏览0引用

DOP085 Higher Clinical Remission and Endoscopic Response with Vedolizumab in Early Versus Late Crohn’s Disease: Data from the LOVE-CD Trial

L Oldenburg,F Baert,P Bossuyt,F Hoentjen,E Clasquin,T Molnar,M Löwenberg,S Vermeire,G D'Haens

Journal of Crohn's and Colitisno. Supplement_1 (2025)

引用0浏览0引用

Directionality of Endoscopic and Histologic Healing in Ulcerative Colitis: a Prospective Pilot Study

Jurij Hanžel,Gregor Novak,Vipul Jairath,Guangyong Zou, Hannah Dong,Xianyong Sean Gui,Pieter Hindryckx,Melanie Beaton,Brian Bressler,Mark Löwenberg,Remo Panaccione,Geert R D'Haens,Brian G Feagan,Christopher Ma

European journal of gastroenterology & hepatologyno. 3 (2025): 304-307

引用0浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn